Dow Down 1.12% Nasdaq Down 1.15%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.93 Down 0.10(1.99%) 12:31PM EDT - Nasdaq Real Time Price
Prev Close:5.03
Open:5.00
Bid:4.86 x 100
Ask:4.93 x 600
1y Target Est:24.00
Beta:1.04
Next Earnings Date:N/A
Day's Range:4.80 - 5.00
52wk Range:4.28 - 19.11
Volume:95,511
Avg Vol (3m):705,853
Market Cap:108.67M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 1.99%108.67M
MNTAUp 0.88%588.98M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.03
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback